Multiple Sclerosis, Secondary Progressive: Clinical Trials

8 trials for Multiple Sclerosis, Secondary Progressive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 completed, 2 recruiting, 1 active not recruiting. 8 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable8Unknown 3, Completed 2, Recruiting 2, Active not recruiting 1

Follow Multiple Sclerosis, Secondary Progressive: new trials by email Literature Review of Multiple Sclerosis, Secondary Progressive trials Research Report on Multiple Sclerosis, Secondary Progressive

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS
Acute Intermittent Hypoxia, Sham Acute Intermittent Hypoxia - Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting
Not applicableRecruitingShirley Ryan AbilityLab222025-02-012026-02-23
The Synergistic Effects of AIH and FES in Persons With MS
Acute Intermittent Hypoxia, Neuromuscular Electrical Stimulation - Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting
Not applicableActive not recruitingShirley Ryan AbilityLab402024-11-012026-02-23
Intermittent Hypoxia in Persons With Multiple Sclerosis
Acute Intermittent Hypoxia, Sham-Acute Intermittent Hypoxia - Multiple Sclerosis, Multiple Sclerosis-Relapsing-Remitting
Not applicableRecruitingShirley Ryan AbilityLab212024-04-302026-03-20
The Effects of In-phase Bilateral Exercise in People with Progressive Multiple Sclerosis
In-phase Bilateral Exercise, Conservative exercises - Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive
Not applicableCompletedCyprus University of Technology202023-10-022024-09-19
MUSCLE - Nordic Walking in MUltiple SCLErosis
Nordic Walking (NWG), Free Walking (FWG), Health Education (HEG) - Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis
Not applicableUnknownLeonardo A. Peyré-Tartaruga602022-08-022022-05-23
Exercise Effects in Multiple Sclerosis
Exercise Group 1, Exercise Group 2, Exercise Group 3 - Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Relapsing-Remitting
Not applicableUnknownUniversity of Regina692022-06-152024-02-15
Discontinuing Disease-modifying Therapies in Stable Relapsing - Onset Multiple Sclerosis (DOT-MS).
DMT - Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting
Not applicableUnknownAmsterdam UMC, location VUmc1302020-07-012020-10-19
Imaging of Intracerebral Inflammation in MS
18F-DPA-714 and 18F-FDG - Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive
Not applicableCompletedAssistance Publique - Hôpitaux de Paris612012-03-192022-09-16

Narrower conditions

Multiple Sclerosis, Chronic Progressive (8)  ·  Multiple Sclerosis (7)  ·  Multiple Sclerosis, Relapsing-Remitting (6)  ·  Hypoxia (3)  ·  Mobility Limitation (1)  ·  Motor Activity (1)  ·  Movement Disorders (1)

Broader conditions

Autoimmune Diseases (8)  ·  Autoimmune Diseases of the Nervous System (8)  ·  Chronic Disease (8)  ·  Demyelinating Autoimmune Diseases, CNS (8)  ·  Demyelinating Diseases (8)  ·  Disease Attributes (8)  ·  Immune System Diseases (8)  ·  Nervous System Diseases (8)  ·  Pathologic Processes (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Signs and Symptoms (4)  ·  Signs and Symptoms, Respiratory (3)  ·  Behavior (1)  ·  Central Nervous System Diseases (1)  ·  Multiple Sclerosis (1)

Interventions

Insemination, Artificial, Homologous (3)  ·  Dimethyl Fumarate (1)  ·  Fluorodeoxyglucose F18 (1)  ·  Glatiramer Acetate (1)  ·  Interferons (1)  ·  Nordic Walking (1)  ·  teriflunomide (1)

Sponsors

Shirley Ryan AbilityLab (3)  ·  Amsterdam UMC, location VUmc (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Cyprus University of Technology (1)  ·  Leonardo A. Peyré-Tartaruga (1)  ·  University of Regina (1)

Countries

United States (3)  ·  Brazil (1)  ·  Canada (1)  ·  Cyprus (1)  ·  France (1)  ·  Netherlands (1)

Top investigators

Bruno Stankoff (1)  ·  Cameron Mang, PhD (1)  ·  Dimitris Sokratous (1)  ·  J. Killestein, prof. dr. (1)  ·  Milap Sandhu (1)  ·  Milap Sandhu, Pt, PhD (1)

Results publications

PMID 12324550, PMID 12525714, PMID 12527959, PMID 20023002, PMID 20156050, PMID 21056491, PMID 23552330, PMID 23869824, PMID 24262162, PMID 27017543, PMID 28017241, PMID 28178885, PMID 28915856, PMID 30844920, PMID 32911307, PMID 34123427, PMID 34197674, PMID 34780079, PMID 34803726, PMID 35084560, PMID 36229188, PMID 37291448, PMID 38129896, PMID 39652340, PMID 6685237

NIH funding

R21HD108587 (1)